• This is defined as a solitary circumscribed pulmonary opacity with no associated pulmonary, pleural, or mediastinal abnormality it measures < 3cm in diameter • Many are discovered incidentally (but up to 40% may be malignant) • The two primary criteria are the rate of growth (or stability over time) and the attenuation of the nodule the patient’s age is also a significant distinguishing feature (a carcinoma is only seen in < 1% of patients < 35 years old) Rate of growth/stability over time: benign lesions invariably have a doubling time of < 1 month or > 18 months (bronchoalveolar carcinomas are an exception in that they may have very slow growth rates) bronchial carcinomas usually have a doubling time of between 1 and 18 months Attenuation/enhancement: a dense central nidus or laminated calcification indicates a granulomatous process (e.g. tuberculosis, histoplasmosis) irregular ‘popcorn’ calcification suggests a hamartoma fat is virtually diagnostic of a hamartoma a lack of enhancement (<15HU) following IV contrast medium is indicative of benignity – Granular calcification is seen on CT in up to 7% of carcinomas (and can represent either tumour calcification or a granuloma engulfed by tumour) – A mixture of soft tissue and ground-glass attenuation nodules is more likely to be malignant than soft tissue nodules alone Size: this is of little diagnostic value Margins: a well-defined mass with a smooth pencil sharp margin is likely to be benign carcinomas typically have ill-defined margins which are irregular, spiculated, or lobulated and may exhibit umbilication or a notch – unfortunately all these features can be seen with benign disease Simulants of solitary pulmonary mass* Extrathoracic artefacts Causes of a solitary pulmonary mass* Bronchial carcinoma Radiological features of solitary pulmonary nodules and the likelihood of malignancy *Likelihood ratio (LR) αBenign calcification: diffuse, central, popcorn or concentric µBenign growth rate: a volume doubling time < 1 month or > 2 years (approximately) βMalignant growth rate: a volume doubling time > 1 month or < 2 years (approximately) Adapted from Erasmus et al. Radiographics 2000; 20: 59–66. • SCLC: small (oat) cell carcinoma This originates from submucosal neuroendocrine cells it rapidly spreads haematogenously and to the lymph nodes it behaves as a systemic disease and is usually disseminated at presentation • NSCLC: non-small cell lung cancer Squamous cell carcinomas: arises from the proximal airway epithelium Large cell carcinomas: atypical cells that appear ‘large’ under the microscope Adenocarcinomas: arising from the bronchial glands Bronchoalveolar carcinoma: an adenocarcinoma subtype arising from the alveoli and adjacent small airways (probably from type II pneumocytes) it presents as peripheral pulmonary opacities • Risks: tobacco smoke (with a 20–30 fold increased risk) – this has the greatest association with squamous cell carcinomas and the weakest association with bronchoalveolar carcinomas asbestos exposure, interstitial pulmonary fibrosis and radiotherapy are additional risks • Asymptomatic (25%): asymptomatic peripheral tumours are more likely to be incidental findings and surgically resectable • Symptomatic: recurrent pneumonia cough wheeze haemoptysis • Paraneoplastic syndromes: inappropriate ADH secretion Cushing’s syndrome (ACTH) carcinoid syndrome hypercalcaemia (PTH) • Poor prognostic features: hoarseness chest pain brachial plexus neuropathy or Horner’s syndrome (due to a Pancoast’s tumour) SVC obstruction dysphagia • The majority are spherical or oval in shape lobulated masses can occur due to uneven growth rates there may be a ‘corona radiata’ due to numerous fine strands radiating into the lung a bronchocele or mucoid impaction can be seen distal to an obstructing carcinoma collapse and consolidation is less commonly seen than with central tumours Cavitation with irregular thick walls ± fluid levels (particularly squamous tumours) Calcification is rare (6–10%) and may represent engulfed granulomatous disease Air bronchograms are rare but can be seen with bronchoalveolar carcinoma and adenocarcinoma • Ground-glass attenuation is associated with a higher risk of malignancy (and commonly seen with bronchoalveolar carcinoma) • This does not preclude surgical resection (although it adversely affects the prognosis) • CT: assessment is unreliable (with local chest wall pain remaining the most specific indicator) contact with or a thickened pleura does not necessarily indicate invasion a clear extrapleural fat plane is helpful but not definitive reliable signs include clear-cut bone destruction or a large soft tissue mass • MRI: this is better than CT in selected cases it is the optimal modality for demonstrating the extent of a superior sulcus tumour • Transthoracic ultrasound: this is an accurate technique • 99mTc radionuclide skeletal scintigraphy: this is sensitive (and may detect bone invasion before plain radiography) • CT/MRI indicators: visible tumour deep within the mediastinal fat (mediastinal contact alone is not enough to diagnose invasion) encasement of the mediastinal vessels, oesophagus, or proximal mainstem bronchi SVC obstruction an elevated hemidiaphragm (indicating phrenic nerve involvement) • Criteria for resectability: < 3cm of contact with the mediastinum < 90° of circumferential contact with the aorta a visible mediastinal fat plane between the mass and any vital mediastinal structure • Irresectability: tumours obliterating fat planes or showing greater contact than that described above
Pulmonary neoplasms
EVALUATION OF THE SOLITARY PULMONARY NODULE
EVALUATION OF THE SOLITARY PULMONARY NODULE
DEFINITION
DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT MASSES
Cutaneous masses
Bony lesions
Pleural tumours of plaques
Encysted pleural fluid
Pulmonary vessel
Bronchial carcinoid
Granuloma
Hamartoma
Metastasis
Chronic pneumonia or abscess
Hytadid cyst
Pulmonary haematoma
Bronchocele
Fungus ball
Massive fibrosis in coal workers
Bronchogenic cyst
Sequestration
Atriovenous malformation
Pulmonary infarct
Round atelectasis
Feature/Characteristic
LR*
Spiculated margin
5.54
>3cm in size
5.23
>70 years of age
4.16
Malignant growth rateβ
3.40
Smoker
2.27
Upper lobe location
1.22
<1cm in size
0.52
Smooth margins
0.30
30–39 years of age
0.24
Never smoked
0.19
20–29 years of age
0.05
Benign calcificationα
0.01
Benign growth rateµ
0.01
LUNG CANCER: RADIOLOGICAL FEATURES
LUNG CANCER: RADIOLOGICAL FEATURES
DEFINITION
CLINICAL PRESENTATION
RADIOLOGICAL FEATURES
Peripheral tumours
Chest wall invasion (T3)
Mediastinal invasion (T4)